Evaluating the Clinical Accuracy of Gallium-68 PSMA PET/CT Imaging in Patients With Biochemical Recurrence of Prostate Cancer

NCT03822845 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

6

Enrollment

OTHER

Sponsor class

Conditions

Prostatic Neoplasms
Prostatic Neoplasms, Castration-Resistant

Interventions

DRUG: Ga-68 PSMA-HBED-CC PET

Sponsor

Michael Graham PhD, MD